C7
protein-codingcomplement C7, the group of Complement system activation components|Sushi domain containing
Gene summary
This gene encodes a serum glycoprotein that forms a membrane attack complex together with complement components C5b, C6, C8, and C9 as part of the terminal complement pathway of the innate immune system. The protein encoded by this gene contains a cholesterol-dependent cytolysin/membrane attack complex/perforin-like (CDC/MACPF) domain and belongs to a large family of structurally related molecules that form pores involved in host immunity and bacterial pathogenesis. This protein initiates membrane attack complex formation by binding the C5b-C6 subcomplex and inserts into the phospholipid bilayer, serving as a membrane anchor. Mutations in this gene are associated with a rare disorder called C7 deficiency. [provided by RefSeq, Nov 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~110.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0012412
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0012412
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0012412
Submitter: Illumina
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious
Intervention: Allergy/Immunology/Infectious
Rationale: Antiinfectious prophylaxis (including related to specific immunization strategies) and early and aggressive treatment of infections may be beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to C7 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000587.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 159 | 3 | 166 | ||
| missense | 2 | 290 | 17 | 1 | 310 | |
| nonsense | 16 | 6 | 1 | 23 | ||
| start loss | 0 | |||||
| frameshift | 18 | 4 | 22 | |||
| splice donor/acceptor (+/-2bp) | 2 | 21 | 5 | 28 | ||
| Total | 36 | 33 | 300 | 176 | 4 | 549 |
Highest pathogenic variant AF is 0.0031138458
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000578.2 | 18 | MANE Select | |
| Ensembl | ENSP00000322061.9 | 18 | MANE Select | |
| Ensembl | ENSP00000512585.1 | 6 | Standard | |
| Ensembl | ENSP00000512585.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Prion diseases - Homo sapiens (human)
- Complement and coagulation cascades - Homo sapiens (human)
- Systemic lupus erythematosus - Homo sapiens (human)
- Allograft Rejection
- Human Complement System
Biological Process
- cellular sodium ion homeostasis
- complement activation
- complement activation, alternative pathway
- complement activation, classical pathway
- cytolysis
Cellular Component
- extracellular region
- membrane attack complex
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000313164
- Coding exons
- 18
- Length
- 73688
- Individuals with no LoFs
- 124364
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 273
- Defined
- 124637
- p
- 0.00110
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.644 | 470 | 432 | 1.09 | 0.0000223 | 5460 |
| Missense (PolyPhen) | 138 | 136.08 | 1.0141 | 1717 | ||
| Synonymous | -1.98 | 193 | 161 | 1.20 | 0.00000906 | 1550 |
| Loss of Function | 2.07 | 29 | 43.8 | 0.663 | 0.00000202 | 593 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0036 | 0.0036 | notable |
| Latino/Admixed American | 0.0013 | 0.0013 | notable |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.0021 | 0.0021 | notable |
| Finnish | 0.00048 | 0.00046 | rare |
| European (Non-Finnish) | 0.0011 | 0.0010 | notable |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0.00088 | 0.00083 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. C7 serves as a membrane anchor.;
- Disease
- DISEASE: Complement component 7 deficiency (C7D) [MIM:610102]: A rare defect of the complement classical pathway associated with susceptibility to severe recurrent infections, predominantly by Neisseria gonorrhoeae or Neisseria meningitidis. {ECO:0000269|PubMed:8871666, ECO:0000269|PubMed:9218625, ECO:0000269|PubMed:9856499}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.108
Intolerance Scores
- LoFtool
- 0.598
- RVIS EVS
- -0.21
- RVIS percentile EVS
- 37.74
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.694
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | High | Medium | High |